Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study
Recommended Citation
Ren Y, Reduzzi C, Regan MM, et al. Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study. Journal of Clinical Oncology. 2023;41(16_suppl):1059-1059. doi:10.1200/JCO.2023.41.16_suppl.1059
Type
Abstract